GOSSELET, FABIEN
GOSSELET, FABIEN
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood–brain barrier under flow
2019 Mossu, A.; Rosito, M.; Khire, T.; Li Chung, H.; Nishihara, H.; Gruber, I.; Luke, E.; Dehouck, L.; Sallusto, F.; Gosselet, F.; Mcgrath, J. L.; Engelhardt, B.
ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier
2017 Lyck, R.; Lecuyer, M. -A.; Abadier, M.; Wyss, C. B.; Matti, C.; Rosito, M.; Enzmann, G.; Zeis, T.; Michel, L.; Garcia Martin, A. B.; Sallusto, F.; Gosselet, F.; Deutsch, U.; Weiner, J. A.; Schaeren-Wiemers, N.; Prat, A.; Engelhardt, B.
Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
2020 Nishihara, H.; Soldati, S.; Mossu, A.; Rosito, M.; Rudolph, H.; Muller, W. A.; Latorre, D.; Sallusto, F.; Sospedra, M.; Martin, R.; Ishikawa, H.; Tenenbaum, T.; Schroten, H.; Gosselet, F.; Engelhardt, B.
Ketone bodies promote amyloid-β1-40 clearance in a human in vitro blood-brain barrier model
2020 Versele, R.; Corsi, M.; Fuso, A.; Sevin, E.; Businaro, R.; Gosselet, F.; Fenart, L.; Candela, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A silicon nanomembrane platform for the visualization of immune cell trafficking across the human blood–brain barrier under flow | 2019 | Mossu, A.; Rosito, M.; Khire, T.; Li Chung, H.; Nishihara, H.; Gruber, I.; Luke, E.; Dehouck, L.; Sallusto, F.; Gosselet, F.; Mcgrath, J. L.; Engelhardt, B. | |
ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier | 2017 | Lyck, R.; Lecuyer, M. -A.; Abadier, M.; Wyss, C. B.; Matti, C.; Rosito, M.; Enzmann, G.; Zeis, T.; Michel, L.; Garcia Martin, A. B.; Sallusto, F.; Gosselet, F.; Deutsch, U.; Weiner, J. A.; Schaeren-Wiemers, N.; Prat, A.; Engelhardt, B. | |
Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro | 2020 | Nishihara, H.; Soldati, S.; Mossu, A.; Rosito, M.; Rudolph, H.; Muller, W. A.; Latorre, D.; Sallusto, F.; Sospedra, M.; Martin, R.; Ishikawa, H.; Tenenbaum, T.; Schroten, H.; Gosselet, F.; Engelhardt, B. | |
Ketone bodies promote amyloid-β1-40 clearance in a human in vitro blood-brain barrier model | 2020 | Versele, R.; Corsi, M.; Fuso, A.; Sevin, E.; Businaro, R.; Gosselet, F.; Fenart, L.; Candela, P. |